A national approach to large-scale inclusive datasets can enable precision health to improve health outcomes and health systems to drive life sciences innovation in Canada. OTTAWA, ON — Today, Genome… Read More
OTTAWA, ON – Following their Annual General Meeting, BioTalent Canada has broadened its leadership team with the announcement of 16 new and returning Board Members. Under the guidance of returning Chair, Reg… Read More
VICTORIA, BC — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced the grant of… Read More
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce… Read More
NEW YORK & MAINZ, GERMANY — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA)… Read More
